Vern Norviel

Vern Norviel retired as a partner and senior practitioner in the patents and innovations practice at Wilson Sonsini Goodrich & Rosati. He retired with over three decades of experience formulating successful strategies for life science companies and helping them develop IP programs. He represented a wide variety of companies, as well as venture capital firms, in areas such as therapeutics, diagnostics, nanotechnology, genomics, proteomics, and personalized medicine. Vern's special interest in the field of personalized medicine prompted him to become the first attorney to have had his or her entire genome sequenced and made available in a public database.vice president and general counsel, he was an early employee of Affymetrix, the biotechnology company that pioneered and developed DNA chip technology. He also had been a partner at Townsend and Townsend and Crew in Palo Alto.

• Life science

• Life science

• MS, Electrical Engineering, Santa Clara University (1987)
• JD, University of San Francisco (1985)
• BS, CU Boulder, Chemical and Biological Engineering (1981)

• Partner, Wilson Sonsini, (2002-2025)
• VP and GC, Affymetrix (1994-2002)
• Partner, Townsend and Townsend and Crew (1985-2002)

• Chambers USA: America's Leading Lawyers for business 
• California's top IP attorneys by the Daily Journal